Your browser doesn't support javascript.
loading
Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic.
Blais, Johanne; Lewis, Stacey R; Krause, Kevin M; Benton, Bret M.
Affiliation
  • Blais J; Theravance, Inc, South San Francisco, California, USA.
Antimicrob Agents Chemother ; 56(3): 1584-7, 2012 Mar.
Article in En | MEDLINE | ID: mdl-22203585
ABSTRACT
TD-1792 is a new multivalent glycopeptide-cephalosporin antibiotic with potent activity against Gram-positive bacteria. The in vitro activity of TD-1792 was tested against 527 Staphylococcus aureus isolates, including multidrug-resistant isolates. TD-1792 was highly active against methicillin-susceptible S. aureus (MIC(90), 0.015 µg/ml), methicillin-resistant S. aureus, and heterogeneous vancomycin-intermediate S. aureus (MIC(90), 0.03 µg/ml). Time-kill studies demonstrated the potent bactericidal activity of TD-1792 at concentrations of ≤ 0.12 µg/ml. A postantibiotic effect of >2 h was observed after exposure to TD-1792.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycopeptides / Cephalosporins / Methicillin-Resistant Staphylococcus aureus / Anti-Bacterial Agents Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2012 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycopeptides / Cephalosporins / Methicillin-Resistant Staphylococcus aureus / Anti-Bacterial Agents Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2012 Document type: Article Affiliation country:
...